2001
DOI: 10.1046/j.0014-2956.2001.02533.x
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, conformational analysis and biological activity of cyclic analogs of the octadecaneuropeptide ODN

Abstract: The octadecaneuropeptide (ODN; QATVGDVNTDRPG LLDLK) and its C-terminal octapeptide (OP; RPGLLDLK), which exert anxiogenic activity, have been previously shown to increase intracellular calcium concentration ([Ca 21 ] i ) in cultured rat astrocytes through activation of a metabotropic receptor positively coupled to phospholipase C. It has also been found that the [7].The mechanism of action of endozepines is not fully understood. It has been initially proposed that these peptides act as inverse agonists … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
76
0

Year Published

2003
2003
2020
2020

Publication Types

Select...
7

Relationship

5
2

Authors

Journals

citations
Cited by 60 publications
(77 citation statements)
references
References 45 publications
1
76
0
Order By: Relevance
“…ODN acts as inverse agonists of central-type benzodiazepine receptors, thus inhibiting the activity of GABA A receptors (Guidotti et al 1983;Tonon et al 1989;Costa and Guidotti 1991;Louiset et al 1993;Do Rego et al 2001). ODN can also activate a metabotropic receptor positively coupled to the phospholipase C cascade through a pertussis toxin-sensitive G-protein (Patte et al 1995;Lamacz et al 1996;Gandolfo et al 1997;Leprince et al 2001).…”
Section: Introductionmentioning
confidence: 98%
“…ODN acts as inverse agonists of central-type benzodiazepine receptors, thus inhibiting the activity of GABA A receptors (Guidotti et al 1983;Tonon et al 1989;Costa and Guidotti 1991;Louiset et al 1993;Do Rego et al 2001). ODN can also activate a metabotropic receptor positively coupled to the phospholipase C cascade through a pertussis toxin-sensitive G-protein (Patte et al 1995;Lamacz et al 1996;Gandolfo et al 1997;Leprince et al 2001).…”
Section: Introductionmentioning
confidence: 98%
“…Human 26RFa (TSGPLGNLAEELNGYS-RKKGGFSFRF-NH 2 ), rat 26RFa (ASGPLGTLAEELSSYSR-RKGGFSFRF-NH 2 ), and frog R-RFa (SLKPAANLPLRF-NH 2 ) were synthesized (0.1-mmol scale) by the solid phase methodology on a Rink amide 4-methylbenzhydrylamine resin (Biochem, Meudon, France) by using a 433A Applied Biosystems peptide synthesizer and the standard fluorenylmethoxycarbonyl (Fmoc) procedure as described (24). The synthetic peptides were purified by reverse-phase HPLC on a 2.2 ϫ 25-cm Vydac 218TP1022 C 18 column (Alltech, Templemars, France) by using a linear gradient (10-50% over 50 min) of acetonitrile͞ trifluoroacetic acid (99.9:0.1, vol͞vol) at a flow rate of 10 ml͞min.…”
Section: Methodsmentioning
confidence: 99%
“…Indeed, the inhibitory effects of ODN on H 2 O 2 -evoked ROS accumulation and LDH leakage were both suppressed by the selective metabotropic ODN receptor antagonist cDOP, but were not affected by the specific CBR antagonist flumazenil. Previous studies have shown that the metabotropic ODN receptor is coupled to either PLC/PKC [28] or AC/PKA signaling pathways [24]. Here, we observed that the AC inhibitor ddA blocked the inhibitory effect of ODN on H 2 O 2 -induced intracellular ROS accumulation, while the PLC inhibitor U73122 had no effect.…”
Section: Discussionmentioning
confidence: 58%
“…Clonazepam and flumazenil were generous gifts from Hoffmann-La Roche (Basle, Switzerland). Rat ODN (QATVGDVNTDRPGLLDLK), the C-terminal octapeptide fragment (RPGLLDLK, OP) and its cyclic analog (cyclo 1-8 [DLeu 5 ]OP, cDOP) were synthesized by using the standard Fmoc procedure, as previously described [28]. All other reagents were of A grade purity.…”
Section: Reagentsmentioning
confidence: 99%
See 1 more Smart Citation